Doyle APC

07/16/2024

CEO pockets more than $82 million in compensation while lying to customers.

Customers who received some of PG&E’s first new underground power lines are shocked by how little the company buried and frustrated by a lack of clear commun...

01/31/2024

📰 January 31, 2024 - Camp Lejeune Update

A new CDC study reveals a link between the contaminated water at Camp Lejeune and an increased incidence of several new types of cancer. The study, initiated by the CDC in 2015, compared cancer risks at Camp Lejeune with marine base Camp Pendleton and found higher rates of certain cancers at Camp Lejeune, including male breast cancer, myeloid cancers (blood cancers), oral cancers, thyroid cancer, and certain types of lung and bladder cancers, leukemias, and lymphomas.

01/02/2024

Camp Lejeune litigation in 2024: What to expect.
With a claim deadline in August 2024, thousands of people exposed to contaminated water at a North Carolina Marine base are suing the government for damages. The first trials will start in 2024 and will decide liability and compensation for different types of cancer claims. The government is also offering early settlements to some victims, but is challenging their right to a jury trial.

In the coming year, litigation over tainted water at Marine Corps Base Camp Lejeune may involve the first trials, which could decide liability and damages for several types of cancer claims as one of the biggest mass torts takes shape.

11/20/2023

In a major legal setback, Bayer has been ordered by a Missouri jury to pay $1.56 billion to four plaintiffs who alleged that the company's Roundup weedkiller, which they used on their family properties, caused non-Hodgkin lymphoma. This verdict is Bayer's fourth consecutive court loss and adds to the company's ongoing litigation challenges despite its stance that Roundup and glyphosate are safe for human use.

A Missouri jury ordered Bayer to pay $1.56 billion to four plaintiffs who claimed the company's Roundup weedkiller caused injuries including cancer, a verdict that could intensify investor pressure on the German drugs and agricultural chemicals company to change its legal strategy.

11/18/2023

The U.S. government has begun settling claims related to the contaminated water at Marine Corps Base Camp Lejeune. More than a year after the PACT Act's enactment, which allows compensation for those affected, the government has made its first payments. Three individuals have accepted settlements totaling $850,000 for injuries caused by the water. Over 117,000 claims and 1,300 lawsuits are pending, with potential costs estimated at $3.3 trillion. The contaminated water, which was present from 1953 to 1987, has been linked to cancer, miscarriages, and other health issues...

More than a year after the enactment of a federal law that provides for compensation to people affected by contaminated water at Marine Corps Base Camp Lejeune, the government has made its first settlement offers and payments, according to court documents.

10/29/2023

Silicosis, an incurable lung disease, is haunting stone fabrication workers due to silica dust exposure. Recent lawsuits aim to bring justice for affected individuals, ensuring they don't face this health crisis alone. Learn more about the ongoing legal battles and how they aim to safeguard workers' rights.👇

Were you or a loved one diagnosed with a silica dust-related illness or suffering from symptoms? Our lawyers are ready to help. Get a free case review today.

08/16/2023

Power company negligence is a common cause of wildfires.

Footage has emerged as key evidence pointing to fallen utility lines as the possible cause of the deadly Maui wildfire. (August 15)(AP video/Haven Daley)

08/03/2023

⚖️ LAWSUIT ALERT 🚨

We're currently reviewing potential lawsuits related to Ozempic, Mounjaro, and Wegovy. These weight loss drugs, initially approved for Type 2 diabetes treatment, have been linked to severe health complications such as Gastroparesis, cholecystitis, and cholelithiasis.

If you or a loved one have experienced any of these health issues after using these drugs, we're here to help. Reach out for a FREE case and medical record review. Understand your rights and explore your potential legal options. https://www.doyleapc.com/ozempic-mounjaro-and-wegovy-lawsuits/

Our personal injury attorneys are reviewing potential Ozempic, Mounjaro, and Wegovy lawsuits for individuals injured after taking the drugs for weight loss. Ozempic®, Mounjaro®, and Wegovy® have been linked to severe injuries like Gastroparesis (stomach paralysis), cholecystitis (inflammation of ...

07/29/2023

Johnson & Johnson's second attempt to resolve the ongoing talc lawsuits through bankruptcy has been rejected by a U.S. judge. This decision puts the proposed $8.9 billion settlement at risk, which was intended to halt new lawsuits from being filed. The judge ruled that the talc lawsuits did not put the company in immediate "financial distress."

A U.S. judge on Friday shot down Johnson & Johnson's second attempt to resolve tens of thousands of lawsuits over its talc products in bankruptcy, imperiling a proposed $8.9 billion settlement that would stop new lawsuits from being filed.

07/27/2023

A recent Reuters investigation reveals that Tesla has been facing a surge of complaints regarding the driving range of their electric vehicles. The report suggests that Tesla's in-dash range estimates may have been overly optimistic, leading to customer dissatisfaction when real-world performance didn't match up. This led to the creation of a 'Diversion Team' within Tesla, tasked with handling and diverting range-related complaints. Read more about it here: https://www.reuters.com/investigates/special-report/tesla-batteries-range/

About a decade ago, Tesla rigged the dashboard readouts in its electric cars to provide “rosy” projections of how far owners can drive before needing to recharge, a source told Reuters.

07/19/2023

New research suggests that up to a quarter of clinical trials in some fields might be flawed or fabricated. John Carlisle, an anesthetist renowned for spotting dubious data in medical trials, found that 44% of over 150 trials he scrutinized had flawed data, and 26% were so problematic that they were considered untrustworthy. The implications are significant, as these flawed studies can mislead medical guidelines and treatment decisions. Experts are calling for stronger scrutiny, including the routine sharing of individual participant data and more rigorous checks for trustworthiness.

Investigations suggest that, in some fields, at least one-quarter of clinical trials might be problematic or even entirely made up, warn some researchers. They urge stronger scrutiny.